A randomized, open-label, phase III trial comparing amrubicin versus docetaxel in patients with previously treated non-small-cell lung cancer
Titel:
A randomized, open-label, phase III trial comparing amrubicin versus docetaxel in patients with previously treated non-small-cell lung cancer
Auteur:
Yoshioka, H. Katakami, N. Okamoto, H. Iwamoto, Y. Seto, T. Takahashi, T. Sunaga, N. Kudoh, S. Chikamori, K. Harada, M. Tanaka, H. Saito, H. Saka, H. Takeda, K. Nogami, N. Masuda, N. Harada, T. Kitagawa, H. Horio, H. Yamanaka, T. Fukuoka, M. Yamamoto, N. Nakagawa, K.